These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 19468028

  • 1. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ, Kwon OJ, Gwak H, Chung JW, Cho SN, Kim WS, Shim TS.
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [Abstract] [Full Text] [Related]

  • 2. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
    Koh WJ, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS.
    J Antimicrob Chemother; 2012 Jun; 67(6):1503-7. PubMed ID: 22403262
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S.
    Clin Infect Dis; 2010 Jan 01; 50(1):49-55. PubMed ID: 19947856
    [Abstract] [Full Text] [Related]

  • 6. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB, Jiang RH, Li L, Xiao HP.
    Int J Tuberc Lung Dis; 2012 Jan 01; 16(3):358-63. PubMed ID: 22640450
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B, Sandven P, Brubakk O.
    J Infect; 2006 Feb 01; 52(2):92-6. PubMed ID: 15907341
    [Abstract] [Full Text] [Related]

  • 8. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW, Chang KC, Chau CH.
    J Antimicrob Chemother; 2009 Nov 01; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract] [Full Text] [Related]

  • 9. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    Koh WJ, Shim TS.
    J Antimicrob Chemother; 2009 Nov 01; 64(5):1119-20. PubMed ID: 19744986
    [No Abstract] [Full Text] [Related]

  • 10. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.
    Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C, TBNET Study Group.
    Eur Respir J; 2009 Aug 01; 34(2):387-93. PubMed ID: 19282348
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
    Roongruangpitayakul C, Chuchottaworn C.
    J Med Assoc Thai; 2013 Oct 01; 96(10):1273-82. PubMed ID: 24350407
    [Abstract] [Full Text] [Related]

  • 12. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
    Singla R, Caminero JA, Jaiswal A, Singla N, Gupta S, Bali RK, Behera D.
    Eur Respir J; 2012 Apr 01; 39(4):956-62. PubMed ID: 21965225
    [Abstract] [Full Text] [Related]

  • 13. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 14. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS, Koh WJ, Kwon OJ, Cho SN, Shim TS.
    Int J Antimicrob Agents; 2009 Jan 15; 33(1):92-3. PubMed ID: 18789655
    [No Abstract] [Full Text] [Related]

  • 15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J, Martín-Dávila P, Navas E, Pérez-Elías MJ, Cobo J, Tato M, De la Pedrosa EG, Gómez-Mampaso E, Moreno S.
    J Antimicrob Chemother; 2005 Jul 15; 56(1):180-5. PubMed ID: 15911549
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    Schaaf HS, Willemse M, Donald PR.
    Pediatr Infect Dis J; 2009 Aug 15; 28(8):748-50. PubMed ID: 19633523
    [Abstract] [Full Text] [Related]

  • 20. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB, TBNET.
    J Antimicrob Chemother; 2009 Oct 15; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.